Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Steroids + Aspirin + Heparin vs Aspirin + Heparin in Pregnant Women with APS
NCT00180778Phase 2Withdrawn
- Sponsor
- Imperial College London
- Start
- Oct 2005
- Primary completion
- Oct 2005
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of prednisolone in antiphospholipid syndrome (APS), sponsored by Imperial College London. Planned start Oct 2005; status: withdrawn.
02
Drugs
prednisolone
03
Conditions
antiphospholipid syndrome (APS)
Beyond the preview
Go deeper on NCT00180778.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00180778.